Purpose
To provide a facility to characterize critical sugar components on HIV vaccine candidates for the Collaboration for AIDS Vaccine Discovery (CAVD)
Grantee
Division
Global Health
Date
OCTOBER 2024
Region served
AFRICA
Committed amount
$1,431,290
Grant topic
HIV
Duration (months)
32
Grantee location
Southampton, Hampshire, United Kingdom
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.